- Details
- Description
Packaging Size:
100c/Bottle
Strength:
0.5mg
Composition:
Anagrelide
Treatment:
Thrombocythemia,Polycythemia Vera
Form:
Capsule
Brand:
LuciAnagre
Quantity Unit:
0.5mg*100c/Box
Manufacturer:
Lucius Pharmaceuticals (Lao) Co.,Ltd
About Anagrelide
Anagrelide is a drug used for the treatment of essential thrombocytosis (also known as essential thrombocythemia), or overproduction of blood platelets. It also has been used in the treatment of chronic myeloid leukemia.
Thrombocythemia
Indicated for essential thrombocythemia and for thrombocythemia secondary to myeloproliferative disorders to decrease risk thrombosis and thrombo-hemorrhagic event
0.5 PO q6hr or 1 mg q12hr; increase PRN not more frequently than 0.5 mg/day/week
Not to exceed 10 mg/day or 2.5 mg/dose
Platelet count responds typically in 7-14 days; time to complete response is 4 to 12 weeks
Polycythemia Vera (Orphan)
